“ú–{–òŠw‰ï ‘æ136”N‰ï�i‰¡•l�j�@2016”N3ŒŽ26“ú(“y)�E27“ú(“ú)�E28“ú(ŒŽ)�E29“ú(‰Î)�@–k—¢‘åŠw–òŠw•” Œö‰vŽÐ’c–@�l “ú–{–òŠw‰ï Œö‰vŽÐ’c–@�l “ú–{–òŠw‰ï Œö‰vŽÐ’c–@�l “ú–{–òŠw‰ï FAQ

3ŒŽ29“ú(‰Î)�@13:15�`14:15�@F‰ï�ê ƒpƒVƒtƒBƒR‰¡•l�@‰ï‹cƒZƒ“ƒ^�[�@3F�@311+312
IS01
ƒhƒCƒc–òŠw‰ï‘ã•\ŽÒ�u‰‰
Special Lectures by DPhG Representatives
ƒI�[ƒKƒiƒCƒU�[�F‘¾“c –Î�A‘åûü �Í

IS01-1
Raising the Gold Standard: Novel Bioisosteric Hinge-Binding Motifs for Tofacitinib-Derived JAK3 Inhibitors
Raising the Gold Standard: Novel Bioisosteric Hinge-Binding Motifs for Tofacitinib-Derived JAK3 Inhibitors
ƒVƒ“ƒ|ƒWƒXƒg �F GEHRINGER M�APFAFFENROT E�AFORSTER M�ABAUER S. M�A�›LAUFER Stefan

IS01-2
The ƒÐ1 receptor as target for the development of novel drugs
The ƒÐ1 receptor as target for the development of novel drugs
ƒVƒ“ƒ|ƒWƒXƒg �F �›WUNSCH Bernhard

ŒŸ�õƒy�[ƒW‚É–ß‚é

TOP‚Ö–ß‚é
ƒvƒ‰ƒCƒoƒV�[ƒ|ƒŠƒV�[‚ɂ‚¢‚Ä
�@Copyright (C) Œö‰vŽÐ’c–@�l“ú–{–òŠw‰ï